🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT

RecruitingNAAges 18 Years - anyAllUniversity of Zurich
NCT06360627 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Evaluation of ultra low dose protocols and Iomeron 400 contrast in PCD-CT

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * CT SCAN for pulmonary nodule detection/follow up * CT SCAN for pneumonia detection/follow up Exclusion Criteria: * under 18 * BMI over 30
💊

What it tests

  • Computed Tomography
📍

Where

1 site
University Hospital Zurich - Diagnostic Radiology
Zurich, Switzerland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy